FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

1162643001: Vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (medicinal product)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4590493012 Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen only vaccine product en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4590494018 2019 novel coronavirus recombinant spike protein antigen vaccine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4590495017 SARS-CoV-2 recombinant spike protein antigen vaccine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
4590497013 COVID-19 recombinant spike protein antigen vaccine en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
4669634011 Vaccine product containing only severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
SARS-CoV-2 recombinant spike protein antigen vaccine Is a SARS-CoV-2 antigen vaccine true Inferred relationship Some
SARS-CoV-2 recombinant spike protein antigen vaccine Plays role Active immunity stimulant role (role) true Inferred relationship Some
SARS-CoV-2 recombinant spike protein antigen vaccine Has active ingredient Severe acute respiratory syndrome coronavirus 2 recombinant spike protein antigen true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group
Adverse reaction to COVID-19 recombinant spike protein antigen vaccine Causative agent True SARS-CoV-2 recombinant spike protein antigen vaccine Inferred relationship Some 1
Administration of SARS-CoV-2 recombinant spike protein antigen vaccine Direct substance True SARS-CoV-2 recombinant spike protein antigen vaccine Inferred relationship Some 1
Administration of second dose of SARS-CoV-2 recombinant spike protein antigen vaccine Direct substance True SARS-CoV-2 recombinant spike protein antigen vaccine Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start